Fabio M. Costa
Evolução, Laboratório De Doenças Tropicais Prof Dr Luiz Jacintho Da Silva
Campinas, SP, Brazil
Campinas, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
Naturally acquired antibodies to Plasmodium vivax Pv_LISP-2, a potential liver stage vaccine antigen.
Journal: Frontiers in immunology
Published: December 08, 2025
Transcriptomics of Plasmodium vivax rosetting
Journal: Memorias do Instituto Oswaldo Cruz
Published: July 30, 2025
Transcriptomics of Plasmodium vivax rosettingFIRST REVIEW ROUND - REVIEWERS COMMENTSREVIEWERS COMMENTS.
Journal: Memorias do Instituto Oswaldo Cruz
Published: July 30, 2025
Metabolic disruptions in P. vivax malaria: Insights from four antimalarial treatment regimens.
Journal: Acta tropica
Published: March 28, 2025
A spatially resolved single-cell lung atlas integrated with clinical and blood signatures distinguishes COVID-19 disease trajectories.
Journal: Science translational medicine
Published: September 11, 2024
Innovative Multistage ML-QSAR Models for Malaria: From Data to Discovery.
Journal: ACS medicinal chemistry letters
Published: July 04, 2024
Exploring the naturally acquired response to Pvs47 gametocyte antigen.
Journal: Frontiers in immunology
Published: June 26, 2024
An experimental target-based platform in yeast for screening Plasmodium vivax deoxyhypusine synthase inhibitors.
Journal: PLoS neglected tropical diseases
Published: June 10, 2024
A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants.
Journal: PLoS pathogens
Published: March 28, 2024
Selective Bias Virtual Screening for Discovery of Promising Antimalarial Candidates targeting Plasmodium N-Myristoyltransferase.
Journal: Research square
Published: March 11, 2024
Host metabolomic responses in recurrent P. vivax malaria.
Journal: Scientific reports
Published: November 10, 2023
Identification of potential inhibitors of casein kinase 2 alpha of Plasmodium falciparum with potent in vitro activity.
Journal: Antimicrobial agents and chemotherapy
Published: October 11, 2023
Last Updated: 09/26/2026